Definitive Contract 75N95022C00025

<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $2,600.00 firm fixed-price purchase order contract to Neurostatus-Uhb AG, a foreign-owned for-profit organization, for a NeuroStatus e-test license and EDSS training. The contract has an ultimate completion date of December 31, 2025 and was awarded on January 1, 2025. The contract was not set aside for any specific business designation.</p>

This federal contract award, with an ID of 75N95019C00049, was made by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), a civilian agency. The purpose of the $15,570,280.46 cost-no-fee definitive contract is to establish collection site(s) (i.e., the NIH Brain and Tissue Repository (NBTR)) to provide services that will actively acquire, receive, process, store, curate, preserve, and distribute central nervous system (CNS) and related...

<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>

<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $183,731.46 firm-fixed-price purchase order contract to Oxford Stemtech LTD for scientific support services related to the generation and multiomics profiling of induced pluripotent stem cell-derived neuronal models. The contract does not have a set-aside designation, and the ultimate completion date is September 10, 2025. This contract award is not associated with a larger acquisition vehicle.</p>

This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $24,250.00, is for the delivery of Brainbox LTD's NEUROFUS DEEP TRANSDUCER, a specialized medical device used to modulate neural activity in deeper areas of the human brain. This technology supports NIDA's research efforts, which include the study of addiction and other neurological conditions. The...

This is a $18,636,390.59 definitive contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. government, to the University of Pittsburgh - Of The Commonwealth System of Higher Education. The contract is for the NEUROBIOBANK BRAIN AND TISSUE REPOSITORY, which will provide services to actively acquire, receive, store, characterize, catalog, preserve, and distribute human brain tissue and biospecimen samples to qualified investigators for research on...

This is a $27,844,029.94 cost-reimbursement contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to The McLean Hospital Corporation, a non-profit psychiatric teaching hospital affiliated with Harvard Medical School. The contract, which runs from September 1, 2019 to August 31, 2020 with options to extend through October 31, 2025, is for the NIH NeuroBioBank Brain and Tissue Repository. This repository collects, stores, and...

The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $25,000 firm fixed price purchase order to Institut DU Cerveau Et De La Moelle Epiniere. The contract requires the prime contractor to host a conference on orbitofrontal function to provide travel awards for academic scientists. The place of performance is Baltimore, Maryland. The period of performance is from August 22, 2023 through August 21, 2024. No set aside designation or...

The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $10,000.00 firm fixed-price purchase order to the Brookings Institution, a nonprofit organization, to provide sponsorship and meeting services. The contract has no set-aside designation and a completion date of September 2, 2011. Brookings has received prior federal contract and grant awards to provide training, research, analysis, publications, and stakeholder engagement services on topics including health...

<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $24,999.10 firm fixed-price purchase order to Vizioli Omics to complete research and analysis leading to the submission of manuscripts for publication. The contract, which does not have a set-aside designation, has a period of performance through June 24, 2025. This award appears to be for a standalone project and is not associated with a larger contract vehicle.</p>